{"id":"https://openalex.org/W2981961965","doi":"https://doi.org/10.1093/ofid/ofz360.772","title":"704. Incidence and Patient Outcomes of S. aureus Isolates from Acute Bacterial Skin and Skin Structure Infections (ABSSSI) with High Iclaprim MIC values in Phase 3 REVIVE Trials","display_name":"704. Incidence and Patient Outcomes of S. aureus Isolates from Acute Bacterial Skin and Skin Structure Infections (ABSSSI) with High Iclaprim MIC values in Phase 3 REVIVE Trials","publication_year":2019,"publication_date":"2019-10-01","ids":{"openalex":"https://openalex.org/W2981961965","doi":"https://doi.org/10.1093/ofid/ofz360.772","mag":"2981961965"},"language":"en","primary_location":{"id":"doi:10.1093/ofid/ofz360.772","doi":"https://doi.org/10.1093/ofid/ofz360.772","is_oa":true,"landing_page_url":"https://doi.org/10.1093/ofid/ofz360.772","pdf_url":"https://academic.oup.com/ofid/article-pdf/6/Supplement_2/S318/30271639/ofz360.772.pdf","source":{"id":"https://openalex.org/S2735126445","display_name":"Open Forum Infectious Diseases","issn_l":"2328-8957","issn":["2328-8957"],"is_oa":true,"is_in_doaj":true,"is_core":true,"listed_in":["cwts-core","doaj","dongbi-c","doyens","jufo-1","ki-jl-1","norway-1","poland-100","russia-white-list-2","vabb-shw"],"host_organization":"https://openalex.org/P4310311648","host_organization_name":"Oxford University Press","host_organization_lineage":["https://openalex.org/P4310311648","https://openalex.org/P4310311647"],"host_organization_lineage_names":["Oxford University Press","University of Oxford"],"type":"journal"},"license":"cc-by-nc-nd","license_id":"https://openalex.org/licenses/cc-by-nc-nd","version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Open Forum Infectious Diseases","raw_type":"journal-article"},"volume":null,"type":"conference-abstract","indexed_in":["crossref","doaj"],"open_access":{"is_oa":true,"oa_status":"gold","oa_url":"https://academic.oup.com/ofid/article-pdf/6/Supplement_2/S318/30271639/ofz360.772.pdf","any_repository_has_fulltext":true},"authorships":[{"author_position":"first","author":{"id":"https://openalex.org/A5016570350","display_name":"David B. Huang","orcid":"https://orcid.org/0000-0001-8228-7911","observed_orcids":["https://orcid.org/0000-0001-8228-7911","https://orcid.org/0000-0002-8342-3193"]},"institutions":[{"id":"https://openalex.org/I4402554120","display_name":"Rutgers New Jersey Medical School","ror":"https://ror.org/014ye1258","country_code":"US","type":"education","lineage":["https://openalex.org/I102322142","https://openalex.org/I4390039302","https://openalex.org/I4402554120"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"David B Huang","raw_affiliation_strings":["Motif Bio / Rutgers New Jersey Medical School, Princeton, New Jersey"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Motif Bio / Rutgers New Jersey Medical School, Princeton, New Jersey","institution_ids":["https://openalex.org/I4402554120"]}]},{"author_position":"middle","author":{"id":null,"display_name":"Cedric Charrier","orcid":null,"observed_orcids":[]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"Cedric Charrier","raw_affiliation_strings":["IHMA Europe, Monthey, Valais, Switzerland"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"IHMA Europe, Monthey, Valais, Switzerland","institution_ids":[]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5077883378","display_name":"Chlo\u00e9 Le Bras","orcid":null,"observed_orcids":[]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"Chloe Le Bras","raw_affiliation_strings":["IHMA, Monthey, Valais, Switzerland"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"IHMA, Monthey, Valais, Switzerland","institution_ids":[]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5063899317","display_name":"Stephen Hawser","orcid":"https://orcid.org/0000-0001-7607-0767","observed_orcids":["https://orcid.org/0000-0001-7607-0767"]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"Stephen Hawser","raw_affiliation_strings":["IHMA, Monthey, Valais, Switzerland"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"IHMA, Monthey, Valais, Switzerland","institution_ids":[]}]},{"author_position":"last","author":{"id":"https://openalex.org/A5004741643","display_name":"Stephanie Noviello","orcid":"https://orcid.org/0000-0001-5555-9328","observed_orcids":["https://orcid.org/0000-0001-5555-9328"]},"institutions":[{"id":"https://openalex.org/I4210140002","display_name":"Motif BioSciences (United States)","ror":"https://ror.org/04815fk53","country_code":"US","type":"company","lineage":["https://openalex.org/I4210140002"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Stephanie S Noviello","raw_affiliation_strings":["Motif BioSciences, Princeton, New Jersey"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Motif BioSciences, Princeton, New Jersey","institution_ids":["https://openalex.org/I4210140002"]}]}],"institutions":[],"countries_distinct_count":1,"institutions_distinct_count":2,"corresponding_author_ids":[],"corresponding_institution_ids":[],"apc_list":{"value":4053,"currency":"USD","value_usd":4053},"apc_paid":{"value":4053,"currency":"USD","value_usd":4053},"fwci":null,"has_fulltext":true,"cited_by_count":0,"citation_normalized_percentile":null,"cited_by_percentile_year":null,"biblio":{"volume":"6","issue":"Supplement_2","first_page":"S318","last_page":"S318"},"is_retracted":false,"is_paratext":false,"is_xpac":false,"primary_topic":{"id":"https://openalex.org/T10195","display_name":"Antimicrobial Resistance in Staphylococcus","score":0.9970999956130981,"subfield":{"id":"https://openalex.org/subfields/2725","display_name":"Infectious Diseases"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},"topics":[{"id":"https://openalex.org/T10195","display_name":"Antimicrobial Resistance in Staphylococcus","score":0.9970999956130981,"subfield":{"id":"https://openalex.org/subfields/2725","display_name":"Infectious Diseases"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},{"id":"https://openalex.org/T10897","display_name":"Antibiotic Use and Resistance","score":0.0005000000237487257,"subfield":{"id":"https://openalex.org/subfields/2402","display_name":"Applied Microbiology and Biotechnology"},"field":{"id":"https://openalex.org/fields/24","display_name":"Immunology and Microbiology"},"domain":{"id":"https://openalex.org/domains/1","display_name":"Life Sciences"}},{"id":"https://openalex.org/T11036","display_name":"Antibiotics Pharmacokinetics and Efficacy","score":0.00039999998989515007,"subfield":{"id":"https://openalex.org/subfields/2736","display_name":"Pharmacology"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}}],"keywords":[{"id":"https://openalex.org/keywords/acute-bacterial-skin-and-skin-structure-infections","display_name":"acute bacterial skin and skin structure infections","score":0.8939999938011169},{"id":"https://openalex.org/keywords/iclaprim","display_name":"iclaprim","score":0.9850000143051147},{"id":"https://openalex.org/keywords/vancomycin","display_name":"vancomycin","score":0.6859999895095825},{"id":"https://openalex.org/keywords/methicillin-resistant-staphylococcus-aureus","display_name":"methicillin-resistant Staphylococcus aureus","score":0.6919999718666077},{"id":"https://openalex.org/keywords/methicillin-susceptible-staphylococcus-aureus","display_name":"methicillin-susceptible Staphylococcus aureus","score":0.9549999833106995},{"id":"https://openalex.org/keywords/early-clinical-response","display_name":"early clinical response","score":0.5440000295639038},{"id":"https://openalex.org/keywords/test-of-cure","display_name":"test of cure","score":0.8939999938011169},{"id":"https://openalex.org/keywords/treatment-outcomes","display_name":"treatment outcomes","score":0.34599998593330383},{"id":"https://openalex.org/keywords/antibiotic-susceptibility","display_name":"antibiotic susceptibility","score":0.37400001287460327},{"id":"https://openalex.org/keywords/vancomycin-resistance","display_name":"vancomycin resistance","score":0.36500000953674316},{"id":"https://openalex.org/keywords/intravenous-antibiotics","display_name":"intravenous antibiotics","score":0.43299999833106995},{"id":"https://openalex.org/keywords/lesion-size-reduction","display_name":"lesion size reduction","score":0.5130000114440918},{"id":"https://openalex.org/keywords/microbiological-cure","display_name":"microbiological cure","score":0.36399999260902405},{"id":"https://openalex.org/keywords/adverse-events","display_name":"adverse events","score":0.5090000033378601}],"concepts":[{"id":"https://openalex.org/C71924100","wikidata":"https://www.wikidata.org/wiki/Q11190","display_name":"Medicine","level":0,"score":0.9207788705825806},{"id":"https://openalex.org/C61511704","wikidata":"https://www.wikidata.org/wiki/Q1671857","display_name":"Incidence (geometry)","level":2,"score":0.5666572451591492},{"id":"https://openalex.org/C203092338","wikidata":"https://www.wikidata.org/wiki/Q1340863","display_name":"Clinical endpoint","level":3,"score":0.5528728365898132},{"id":"https://openalex.org/C2908647359","wikidata":"https://www.wikidata.org/wiki/Q2625603","display_name":"Population","level":2,"score":0.4776105582714081},{"id":"https://openalex.org/C126322002","wikidata":"https://www.wikidata.org/wiki/Q11180","display_name":"Internal medicine","level":1,"score":0.4629325270652771},{"id":"https://openalex.org/C197934379","wikidata":"https://www.wikidata.org/wiki/Q2047938","display_name":"Adverse effect","level":2,"score":0.4322606921195984},{"id":"https://openalex.org/C2778980435","wikidata":"https://www.wikidata.org/wiki/Q424027","display_name":"Vancomycin","level":4,"score":0.42207375168800354},{"id":"https://openalex.org/C141071460","wikidata":"https://www.wikidata.org/wiki/Q40821","display_name":"Surgery","level":1,"score":0.40732812881469727},{"id":"https://openalex.org/C535046627","wikidata":"https://www.wikidata.org/wiki/Q30612","display_name":"Clinical trial","level":2,"score":0.4072364866733551},{"id":"https://openalex.org/C2779489039","wikidata":"https://www.wikidata.org/wiki/Q188121","display_name":"Staphylococcus aureus","level":3,"score":0.3469003140926361},{"id":"https://openalex.org/C120665830","wikidata":"https://www.wikidata.org/wiki/Q14620","display_name":"Optics","level":1,"score":0.0},{"id":"https://openalex.org/C54355233","wikidata":"https://www.wikidata.org/wiki/Q7162","display_name":"Genetics","level":1,"score":0.0},{"id":"https://openalex.org/C86803240","wikidata":"https://www.wikidata.org/wiki/Q420","display_name":"Biology","level":0,"score":0.0},{"id":"https://openalex.org/C121332964","wikidata":"https://www.wikidata.org/wiki/Q413","display_name":"Physics","level":0,"score":0.0},{"id":"https://openalex.org/C99454951","wikidata":"https://www.wikidata.org/wiki/Q932068","display_name":"Environmental health","level":1,"score":0.0},{"id":"https://openalex.org/C523546767","wikidata":"https://www.wikidata.org/wiki/Q10876","display_name":"Bacteria","level":2,"score":0.0}],"mesh":[],"locations_count":2,"locations":[{"id":"doi:10.1093/ofid/ofz360.772","doi":"https://doi.org/10.1093/ofid/ofz360.772","is_oa":true,"landing_page_url":"https://doi.org/10.1093/ofid/ofz360.772","pdf_url":"https://academic.oup.com/ofid/article-pdf/6/Supplement_2/S318/30271639/ofz360.772.pdf","source":{"id":"https://openalex.org/S2735126445","display_name":"Open Forum Infectious Diseases","issn_l":"2328-8957","issn":["2328-8957"],"is_oa":true,"is_in_doaj":true,"is_core":true,"listed_in":["cwts-core","doaj","dongbi-c","doyens","jufo-1","ki-jl-1","norway-1","poland-100","russia-white-list-2","vabb-shw"],"host_organization":"https://openalex.org/P4310311648","host_organization_name":"Oxford University Press","host_organization_lineage":["https://openalex.org/P4310311648","https://openalex.org/P4310311647"],"host_organization_lineage_names":["Oxford University Press","University of Oxford"],"type":"journal"},"license":"cc-by-nc-nd","license_id":"https://openalex.org/licenses/cc-by-nc-nd","version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Open Forum Infectious Diseases","raw_type":"journal-article"},{"id":"pmh:oai:pubmedcentral.nih.gov:6811073","doi":null,"is_oa":true,"landing_page_url":"https://www.ncbi.nlm.nih.gov/pmc/articles/6811073","pdf_url":null,"source":{"id":"https://openalex.org/S2764455111","display_name":"PubMed Central","issn_l":null,"issn":null,"is_oa":true,"is_in_doaj":false,"is_core":false,"listed_in":[],"host_organization":"https://openalex.org/I1299303238","host_organization_name":"National Institutes of Health","host_organization_lineage":["https://openalex.org/I1299303238"],"host_organization_lineage_names":[],"type":"repository"},"license":"cc-by-nc-nd","license_id":"https://openalex.org/licenses/cc-by-nc-nd","version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Open Forum Infect Dis","raw_type":"Text"}],"best_oa_location":{"id":"doi:10.1093/ofid/ofz360.772","doi":"https://doi.org/10.1093/ofid/ofz360.772","is_oa":true,"landing_page_url":"https://doi.org/10.1093/ofid/ofz360.772","pdf_url":"https://academic.oup.com/ofid/article-pdf/6/Supplement_2/S318/30271639/ofz360.772.pdf","source":{"id":"https://openalex.org/S2735126445","display_name":"Open Forum Infectious Diseases","issn_l":"2328-8957","issn":["2328-8957"],"is_oa":true,"is_in_doaj":true,"is_core":true,"listed_in":["cwts-core","doaj","dongbi-c","doyens","jufo-1","ki-jl-1","norway-1","poland-100","russia-white-list-2","vabb-shw"],"host_organization":"https://openalex.org/P4310311648","host_organization_name":"Oxford University Press","host_organization_lineage":["https://openalex.org/P4310311648","https://openalex.org/P4310311647"],"host_organization_lineage_names":["Oxford University Press","University of Oxford"],"type":"journal"},"license":"cc-by-nc-nd","license_id":"https://openalex.org/licenses/cc-by-nc-nd","version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Open Forum Infectious Diseases","raw_type":"journal-article"},"sustainable_development_goals":[{"score":1.0,"display_name":"Good health and well-being","id":"https://metadata.un.org/sdg/3"}],"study_designs":[],"awards":[],"funders":[],"has_content":{"pdf":true,"grobid_xml":true},"content_urls":{"pdf":"https://content.openalex.org/works/W2981961965.pdf","grobid_xml":"https://content.openalex.org/works/W2981961965.grobid-xml"},"referenced_works_count":0,"referenced_works":[],"related_works":["https://openalex.org/W2943808544","https://openalex.org/W2778606863","https://openalex.org/W2752713307","https://openalex.org/W2804406807","https://openalex.org/W3010816592","https://openalex.org/W2789912955","https://openalex.org/W2940825000","https://openalex.org/W4295935779","https://openalex.org/W2158190550","https://openalex.org/W2909927190"],"abstract_inverted_index":{"Abstract":[0],"Background":[1],"The":[2,212,240],"incidence":[3,213],"and":[4,40,44,62,161,173,191,200,236,256,277,307,330,351],"outcomes":[5,242,265],"of":[6,37,64,140,142,158,163,170,175,185,214,243,248,253,260,266,271,280,321,327,341],"patients":[7,28,55,221,301],"with":[8,12,56,70,106,127,208,222,224,336,358],"S.":[9,217,297,355],"aureus":[10,218,298,356],"isolates":[11,219,357],"an":[13,225,359],"iclaprim":[14,65,226,347,360],"MIC":[15,227,326,340,361],">8":[16,228,362],"\u00b5g/mL,":[17,363],"a":[18,92,103,107,120,309,324,334,339],"concentration":[19],"that":[20,58],"is":[21],"not":[22],"systemically":[23],"achievable,":[24],"were":[25,47,195,234,238,303],"determined":[26],"among":[27,54,220,295],"from":[29,312,333],"two":[30],"Phase":[31],"3":[32],"studies":[33,46],"for":[34,75,87,197],"the":[35,60,130,138,143,147,168,182,257,269,278,296,315],"treatment":[36],"ABSSSI,":[38,314],"REVIVE-1":[39,43],"-2.":[41],"Methods":[42],"REVIVE-2":[45],"600-patient,":[48],"double-blinded,":[49],"randomized":[50,304],"(1:1),":[51],"active-controlled":[52],"trials":[53],"ABSSSI":[57,164,223],"compared":[59,126],"safety":[61],"efficacy":[63],"80":[66],"mg":[67],"fixed":[68],"dose":[69,184],"vancomycin":[71,293,306,325],"15":[72],"mg/kg":[73],"(adjusted":[74],"renal":[76],"function),":[77],"both":[78],"administered":[79],"intravenously":[80],"over":[81],"2":[82,342],"hours":[83,86,136],"every":[84],"12":[85],"5\u201314":[88],"days.":[89],"Patients":[90,345],"had":[91,308,338,348],"bacterial":[93],"skin":[94],"infection":[95],"suspected":[96],"or":[97],"confirmed":[98,216],"to":[99,102,305],"be":[100],"due":[101],"Gram-positive":[104],"pathogen":[105,310],"lesion":[108,124],"size":[109,125],"\u226575":[110],"cm2.":[111],"An":[112],"early":[113,131],"clinical":[114,152,241,350],"response":[115,252,259,273,282],"(ECR)":[116],"was":[117,165,230,274,283,289,318],"defined":[118,154],"as":[119,155],"\u226520%":[121],"reduction":[122],"in":[123,146,206,292],"baseline":[128],"at":[129,167,323],"time":[132],"point":[133],"(ETP)":[134],"48\u201372":[135],"after":[137,181],"start":[139],"administration":[141],"study":[144,186],"drug":[145],"intent-to-treat":[148],"(ITT)":[149],"population.":[150],"A":[151],"cure,":[153],"complete":[156],"resolution":[157],"all":[159],"signs":[160],"symptoms":[162],"measured":[166],"end":[169,270],"therapy":[171,272],"(EOT)":[172],"test":[174,279],"cure":[176,281],"(TOC)":[177],"visit,":[178],"7\u201314":[179],"days":[180],"last":[183],"drug.":[187],"At":[188],"baseline,":[189],"EOT":[190,251],"TOC":[192,258],"visits,":[193],"ABSSSIs":[194],"sampled":[196],"microbiological":[198,264,352],"culture":[199,215],"broth":[201],"microdilution":[202],"susceptibility":[203],"testing":[204],"conducted":[205],"accordance":[207],"CLSI":[209],"M7.":[210],"Results":[211],"\u00b5g/mL":[229,329],"2.0%":[231],"(16/790).":[232],"Six":[233],"MSSA":[235],"10":[237],"MRSA.":[239],"these":[244,267],"infections":[245],"included":[246],"ECR":[247,317,337],"63%":[249],"(10/16),":[250],"81.3%":[254],"(13/16)":[255],"75%":[261],"(12/16).":[262],"For":[263,300],"infections,":[268],"92.9%":[275],"(13/14)":[276],"92.3%":[284],"(12/13).":[285],"In":[286],"comparison,":[287],"there":[288],"less":[290],"variation":[291],"MICs":[294],"isolates.":[299],"who":[302],"identified":[311],"their":[313],"pooled":[316],"82.6%":[319],"(242":[320],"293)":[322],"0.5\u20131":[328],"one":[331],"isolate":[332],"patient":[335],"\u00b5g/mL.":[343],"Conclusion":[344],"receiving":[346],"good":[349],"responses":[353],"against":[354],"which":[364],"are":[365],"uncommon":[366],"(2.0%).":[367],"Disclosures":[368],"All":[369],"authors:":[370],"No":[371],"reported":[372],"disclosures.":[373]},"counts_by_year":[],"updated_date":"2026-10-27T15:51:10.671819","created_date":"2019-11-01T00:00:00"}